Bayer to acquire birth control firm Conceptus for $1.1 billion
11:48 AM MDT | April 29, 2013
Bayer HealthCare has signed a merger agreement with Conceptus (Mountain View; CA), the developer of the Essure procedureâ€”a leading nonsurgical, permanent birth-control method, Bayer announced today. Bayer, following the acquisition, will be able to offer a complete range of short-term, long-term, and permanent contraceptive choices for women, the company says. Bayer will launch a public tender offer to acquire all shares in Conceptus within the next 10 business days in a transaction valuing Conceptus at approximately $1.1 billion, representing $31.00/share in...
Access is for Chemweek 24/7 PLUS Members ONLY
This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information.
Forgot your user ID or password? Click here to have it sent to you.